Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6175237 | 0.88 | CCR6 (0.43) | PDE2A | |
| SCHEMBL6176024 | 0.80 | IGF1R (0.41) | IGF1RPDE2A | |
| SCHEMBL6174879 | 0.77 | IGF1R (0.40) | IGF1RPDE2A | |
| SCHEMBL6174088 | 0.76 | IGF1R (0.42) | IGF1RPDE2A | |
| SCHEMBL6173512 | 0.74 | ADRB1 (0.40) | IGF1R | |
| SCHEMBL6172644 | 0.74 | IGF1R (0.40) | IGF1R | |
| SCHEMBL6173502 | 0.73 | IGF1R (0.38) | IGF1R | |
| SCHEMBL6174968 | 0.73 | ITGB2 (0.39) | IGF1R | |
| SCHEMBL6174814 | 0.70 | IGF1R (0.45) | IGF1R | |
| SCHEMBL2938288 | 0.70 | IGF1R (0.72) | IGF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599464-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004070050-A2 | CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2004-08-19 | — | — | WO | disclosed |